Nasal Drug Delivery Market
完整報告名稱與涵蓋範圍
Nasal Drug Delivery Market Size, Share & Trends Analysis Report, By Dosage Form (Nasal Sprays and Solutions, Nasal Powders, Nasal Gels, Drops and Ointments), By Device Type (Multi-Dose Metered Pump Sprays, Unit-Dose and Bi-Dose Devices, Powder and Breath-Powered Devices, Emerging Precision Deposition Devices), By Therapeutic Application (Allergic Rhinitis and Nasal Congestion, Migraine and Acute Pain, CNS, Emergency and Rescue Medications, Vaccines and Anti-Infectives, Hormone and Systemic Therapies), By Distribution Channel, By Region, and Segment Forecasts, 2026-2035
報告摘要
The nasal drug delivery market covers prescription and over-the-counter medicines formulated for intranasal administration and the spray, powder and precision-deposition devices used to deliver them, spanning local treatments for rhinitis and congestion, systemic therapies for migraine, pain and rescue indications, hormone and peptide products and nasal vaccines. Nasal saline and cosmetic products are excluded, as are inhaled pulmonary products.
The route has moved well beyond decongestants: intranasal naloxone, glucagon, epinephrine and benzodiazepines have made the nose the preferred route for emergency and rescue medicines, needle-free intranasal migraine therapies compete with oral triptans and gepants, and breath-powered and precision devices target the upper nasal cavity to improve systemic absorption. Generic and over-the-counter switches of steroid sprays sustain volume while device innovation, formulation science for peptides and larger molecules and interest in mucosal vaccines drive value. Device-drug combination regulation, bioequivalence standards for nasal generics and reliance on a concentrated group of pump suppliers shape competition.
North America and Europe generate most revenue, with Asia Pacific the fastest-growing region on allergy prevalence and expanding pharmacy access. Competition involves device and primary packaging specialists, nasal formulation CDMOs and pharmaceutical franchises across allergy, migraine, emergency and CNS therapy.
The InsightAce study includes revenue forecasts in US$ for all dosage form, device type, therapeutic application and distribution channel and regional segments across 2026-2035, segment-level trend analysis, competitive positioning assessment and company profiles.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Nasal Drug Delivery Market Snapshot
Chapter 4. Global Nasal Drug Delivery Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Dosage Form Estimates & Trend Analysis
5.1. Dosage Form & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Dosage Form:
5.2.1. Nasal Sprays and Solutions
5.2.2. Nasal Powders
5.2.3. Nasal Gels, Drops and Ointments
Chapter 6. Market Segmentation 2: By Device Type Estimates & Trend Analysis
6.1. Device Type & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Device Type:
6.2.1. Multi-Dose Metered Pump Sprays
6.2.2. Unit-Dose and Bi-Dose Devices
6.2.3. Powder and Breath-Powered Devices
6.2.4. Emerging Precision Deposition Devices
Chapter 7. Market Segmentation 3: By Therapeutic Application Estimates & Trend Analysis
7.1. Therapeutic Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Therapeutic Application:
7.2.1. Allergic Rhinitis and Nasal Congestion
7.2.2. Migraine and Acute Pain
7.2.3. CNS, Emergency and Rescue Medications
7.2.4. Vaccines and Anti-Infectives
7.2.5. Hormone and Systemic Therapies
Chapter 8. Market Segmentation 4: By Distribution Channel Estimates & Trend Analysis
8.1. Distribution Channel & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Distribution Channel:
8.2.1. Retail Pharmacies and OTC
8.2.2. Hospital Pharmacies
8.2.3. Online Pharmacies
Chapter 9. Nasal Drug Delivery Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Aptar Pharma
11.2. Becton, Dickinson and Company
11.3. Nemera
11.4. Silgan Dispensing Systems
11.5. Recipharm AB
11.6. Bespak (Recipharm)
11.7. Hikma Pharmaceuticals PLC
11.8. Emergent BioSolutions Inc.
11.9. Pfizer Inc.
11.10. Bausch Health Companies Inc.
11.11. GSK plc
11.12. Sanofi
11.13. Kyowa Kirin Co., Ltd.
11.14. Impel Pharmaceuticals (Vectura Fertin Pharma)
11.15. OptiNose, Inc.
圖表清單 List of Tables & Figures
Table 1. Global Nasal Drug Delivery Market Revenue Forecast by Dosage Form, 2026-2035 (US$ Mn)
Figure 1. Global Nasal Drug Delivery Market Segmentation Overview
Table 2. Global Nasal Drug Delivery Market Revenue Forecast by Device Type, 2026-2035 (US$ Mn)
Figure 2. Global Nasal Drug Delivery Market Share by Dosage Form, 2026 & 2035
Table 3. Global Nasal Drug Delivery Market Revenue Forecast by Therapeutic Application, 2026-2035 (US$ Mn)
Figure 3. Nasal Delivery Applications from Local Rhinitis Treatment to Systemic Emergency Medicines
Table 4. Global Nasal Drug Delivery Market Revenue Forecast by Distribution Channel, 2026-2035 (US$ Mn)
Figure 4. Global Nasal Drug Delivery Market Share by Device Type, 2026 & 2035
Table 5. North America Nasal Drug Delivery Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Device Innovation Landscape: Multi-Dose, Unit-Dose, Powder and Precision Deposition
Table 6. Europe Nasal Drug Delivery Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific Nasal Drug Delivery Growth Opportunity Analysis
Table 7. Asia Pacific Nasal Drug Delivery Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Regulatory and Bioequivalence Considerations for Nasal Generics and Combination Products
Table 8. Latin America Nasal Drug Delivery Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key Nasal Drug Delivery Market Participants
Table 9. Middle East & Africa Nasal Drug Delivery Market Revenue by Country, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們